320 related articles for article (PubMed ID: 34488770)
1. Risk factors for Plasmodium falciparum infection in pregnant women in Burkina Faso: a community-based cross-sectional survey.
Yaro JB; Ouedraogo A; Diarra A; Sombié S; Ouedraogo ZA; Nébié I; Drakeley C; Sirima SB; Tiono AB; Lindsay SW; Wilson AL
Malar J; 2021 Sep; 20(1):362. PubMed ID: 34488770
[TBL] [Abstract][Full Text] [Related]
2. Increase in the prevalence of mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates collected from early to late pregnancy in Nanoro, Burkina Faso.
Ruizendaal E; Tahita MC; Geskus RB; Versteeg I; Scott S; d'Alessandro U; Lompo P; Derra K; Traore-Coulibaly M; de Jong MD; Schallig HDFH; Tinto H; Mens PF
Malar J; 2017 Apr; 16(1):179. PubMed ID: 28454537
[TBL] [Abstract][Full Text] [Related]
3. Malaria prevention during pregnancy: assessing the disease burden one year after implementing a program of intermittent preventive treatment in Koupela District, Burkina Faso.
Sirima SB; Cotte AH; Konaté A; Moran AC; Asamoa K; Bougouma EC; Diarra A; Ouédraogo A; Parise ME; Newman RD
Am J Trop Med Hyg; 2006 Aug; 75(2):205-11. PubMed ID: 16896120
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and risk factors for Plasmodium falciparum malaria in pregnant women attending antenatal clinic in Bobo-Dioulasso (Burkina Faso).
Cisse M; Sangare I; Lougue G; Bamba S; Bayane D; Guiguemde RT
BMC Infect Dis; 2014 Nov; 14():631. PubMed ID: 25408152
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and factors associated with carriage of Pfmdr1 polymorphisms among pregnant women receiving intermittent preventive treatment with sulfadoxine-pyrimethamine (IPTp-SP) and artemether-lumefantrine for malaria treatment in Burkina Faso.
Natama HM; Toussaint R; Bazié DLC; Samadoulougou S; Coulibaly-Traoré M; Tinto H; Kirakoya-Samadoulougou F
Malar J; 2020 Nov; 19(1):399. PubMed ID: 33172485
[TBL] [Abstract][Full Text] [Related]
6. Malaria prevention in pregnancy, birthweight, and neonatal mortality: a meta-analysis of 32 national cross-sectional datasets in Africa.
Eisele TP; Larsen DA; Anglewicz PA; Keating J; Yukich J; Bennett A; Hutchinson P; Steketee RW
Lancet Infect Dis; 2012 Dec; 12(12):942-9. PubMed ID: 22995852
[TBL] [Abstract][Full Text] [Related]
7. Decrease of microscopic Plasmodium falciparum infection prevalence during pregnancy following IPTp-SP implementation in urban cities of Gabon.
Bouyou-Akotet MK; Mawili-Mboumba DP; Kendjo E; Moutandou Chiesa S; Tshibola Mbuyi ML; Tsoumbou-Bakana G; Zong J; Ambounda N; Kombila M
Trans R Soc Trop Med Hyg; 2016 Jun; 110(6):333-42. PubMed ID: 27268713
[TBL] [Abstract][Full Text] [Related]
8. Recent uptake of intermittent preventive treatment during pregnancy with sulfadoxine-pyrimethamine is associated with increased prevalence of Pfdhfr mutations in Bobo-Dioulasso, Burkina Faso.
Cisse M; Awandare GA; Soulama A; Tinto H; Hayette MP; Guiguemdé RT
Malar J; 2017 Jan; 16(1):38. PubMed ID: 28114990
[TBL] [Abstract][Full Text] [Related]
9. Decline of placental malaria in southern Ghana after the implementation of intermittent preventive treatment in pregnancy.
Hommerich L; von Oertzen C; Bedu-Addo G; Holmberg V; Acquah PA; Eggelte TA; Bienzle U; Mockenhaupt FP
Malar J; 2007 Nov; 6():144. PubMed ID: 17996048
[TBL] [Abstract][Full Text] [Related]
10. Safety and toxicity of sulfadoxine/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment.
Peters PJ; Thigpen MC; Parise ME; Newman RD
Drug Saf; 2007; 30(6):481-501. PubMed ID: 17536875
[TBL] [Abstract][Full Text] [Related]
11. Predictors for the uptake of optimal doses of sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria during pregnancy in Tanzania: further analysis of the data of the 2015-2016 Tanzania demographic and health survey and malaria indicator survey.
Mushi V; Mbotwa CH; Zacharia A; Ambrose T; Moshi FV
Malar J; 2021 Feb; 20(1):75. PubMed ID: 33549094
[TBL] [Abstract][Full Text] [Related]
12. Antenatal receipt of sulfadoxine-pyrimethamine does not exacerbate pregnancy-associated malaria despite the expansion of drug-resistant Plasmodium falciparum: clinical outcomes from the QuEERPAM study.
Taylor SM; Antonia AL; Chaluluka E; Mwapasa V; Feng G; Molyneux ME; ter Kuile FO; Meshnick SR; Rogerson SJ
Clin Infect Dis; 2012 Jul; 55(1):42-50. PubMed ID: 22441649
[TBL] [Abstract][Full Text] [Related]
13. An analysis of timing and frequency of malaria infection during pregnancy in relation to the risk of low birth weight, anaemia and perinatal mortality in Burkina Faso.
Valea I; Tinto H; Drabo MK; Huybregts L; Sorgho H; Ouedraogo JB; Guiguemde RT; van Geertruyden JP; Kolsteren P; D'Alessandro U;
Malar J; 2012 Mar; 11():71. PubMed ID: 22433778
[TBL] [Abstract][Full Text] [Related]
14. A cluster randomized trial of delivery of intermittent preventive treatment of malaria in pregnancy at the community level in Burkina Faso.
Gutman JR; Stephens DK; Tiendrebeogo J; Badolo O; Dodo M; Burke D; Williamson J; Vibbert K; Youll SJ; Savadogo Y; Brieger WR
Malar J; 2020 Aug; 19(1):282. PubMed ID: 32758233
[TBL] [Abstract][Full Text] [Related]
15. Intermittent preventive treatment with Sulphadoxine-Pyrimethamine (IPTp-SP) is associated with protection against sub-microscopic P. falciparum infection in pregnant women during the low transmission dry season in southwestern Cameroon: A Semi - longitudinal study.
Apinjoh TO; Ntui VN; Chi HF; Moyeh MN; Toussi CT; Mayaba JM; Tangi LN; Kwi PN; Anchang-Kimbi JK; Dionne-Odom J; Tita ATN; Achidi EA; Amambua-Ngwa A; Titanji VPK
PLoS One; 2022; 17(9):e0275370. PubMed ID: 36178962
[TBL] [Abstract][Full Text] [Related]
16. Individual efficacy of intermittent preventive treatment with sulfadoxine-pyrimethamine in primi- and secundigravidae in rural Burkina Faso: impact on parasitaemia, anaemia and birth weight.
Gies S; Coulibaly SO; Ouattara FT; D'Alessandro U
Trop Med Int Health; 2009 Feb; 14(2):174-82. PubMed ID: 19171009
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the usage and effectiveness of intermittent preventive treatment and insecticide-treated nets on the indicators of malaria among pregnant women attending antenatal care in the Buea Health District, Cameroon.
Fokam EB; Ngimuh L; Anchang-Kimbi JK; Wanji S
Malar J; 2016 Mar; 15():172. PubMed ID: 26987387
[TBL] [Abstract][Full Text] [Related]
18. Risk of Plasmodium falciparum infection in south-west Burkina Faso: potential impact of expanding eligibility for seasonal malaria chemoprevention.
Yaro JB; Tiono AB; Ouedraogo A; Lambert B; Ouedraogo ZA; Diarra A; Traore A; Lankouande M; Soulama I; Sanou A; Worrall E; Agboraw E; Sagnon N; Ranson H; Churcher TS; Lindsay SW; Wilson AL
Sci Rep; 2022 Jan; 12(1):1402. PubMed ID: 35082312
[TBL] [Abstract][Full Text] [Related]
19. A community effectiveness trial of strategies promoting intermittent preventive treatment with sulphadoxine-pyrimethamine in pregnant women in rural Burkina Faso.
Gies S; Coulibaly SO; Ouattara FT; Ky C; Brabin BJ; D'Alessandro U
Malar J; 2008 Sep; 7():180. PubMed ID: 18801158
[TBL] [Abstract][Full Text] [Related]
20. Presence of quintuple dhfr N51, C59, S108 - dhps A437, K540 mutations in Plasmodium falciparum isolates from pregnant women and the general population in Nanoro, Burkina Faso.
Ruizendaal E; Tahita MC; Traoré-Coulibaly M; Tinto H; Schallig HDFH; Mens PF
Mol Biochem Parasitol; 2017 Oct; 217():13-15. PubMed ID: 28818675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
